Detailed answers about PHARMEX HOLDINGS LIMITED, including incorporation, status, business activity, and accounts information.
When was PHARMEX HOLDINGS LIMITED founded?
PHARMEX HOLDINGS LIMITED was officially incorporated on 22 June 2023 and is registered under company number 14953331. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is PHARMEX HOLDINGS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of PHARMEX HOLDINGS LIMITED?
PHARMEX HOLDINGS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does PHARMEX HOLDINGS LIMITED do?
PHARMEX HOLDINGS LIMITED operates in the following sector: 86900 - Other human health activities. This provides insight into the company's primary business activity and industry focus.
What is PHARMEX HOLDINGS LIMITED's registered address?
The registered office address of PHARMEX HOLDINGS LIMITED is 121 HENLEY ROAD, ILFORD, ENGLAND, IG1 2TS. This is the official address filed with Companies House for legal and statutory correspondence.
Is PHARMEX HOLDINGS LIMITED financially stable?
The most recent accounts for PHARMEX HOLDINGS LIMITED were made up to 30 June 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 March 2026.
Does PHARMEX HOLDINGS LIMITED have any charges or mortgages?
PHARMEX HOLDINGS LIMITED has 1 registered charge, of which 1 is outstanding, 0 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.